Heart angiotensin-converting enzyme activity increased after intraperitoneal bleomycin administration in rat.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000633:toxicity; D001761:Bleomycin / Q000008:administration & dosage / Q000633:toxicity*; D004789:Enzyme Activation / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D008168:Lung / Q000187:drug effects / Q000201:enzymology; D055370:Lung Injury; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D007703:Peptidyl-Dipeptidase A / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D007703:Peptidyl-Dipeptidase A